FR1172M - New drug especially for the treatment of ovarian irregularities and insufficiencies. - Google Patents

New drug especially for the treatment of ovarian irregularities and insufficiencies.

Info

Publication number
FR1172M
FR1172M FR850722A FR850722A FR1172M FR 1172 M FR1172 M FR 1172M FR 850722 A FR850722 A FR 850722A FR 850722 A FR850722 A FR 850722A FR 1172 M FR1172 M FR 1172M
Authority
FR
France
Prior art keywords
insufficiencies
ovarian
irregularities
treatment
new drug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR850722A
Other languages
French (fr)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR850722A priority Critical patent/FR1172M/en
Priority to SE1034761A priority patent/SE300972B/xx
Priority to GB3769861A priority patent/GB930885A/en
Priority to DK425261A priority patent/DK104567C/en
Priority to ES271517A priority patent/ES271517A1/en
Priority to BE609700A priority patent/BE609700A/en
Priority to CH1244961A priority patent/CH395978A/en
Application granted granted Critical
Publication of FR1172M publication Critical patent/FR1172M/en
Active legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J75/00—Processes for the preparation of steroids in general

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
FR850722A 1960-10-27 1961-01-25 New drug especially for the treatment of ovarian irregularities and insufficiencies. Active FR1172M (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR850722A FR1172M (en) 1960-10-27 1961-01-25 New drug especially for the treatment of ovarian irregularities and insufficiencies.
SE1034761A SE300972B (en) 1960-10-27 1961-10-18
GB3769861A GB930885A (en) 1960-10-27 1961-10-20 Processes for the production of steroid esters and the new steroid esters thus produced
DK425261A DK104567C (en) 1960-10-27 1961-10-26 Process for the preparation of 17-monocyclohexylcarbonates of 17-hydroxysteroids of androstanels of the oyster row, 3-monocyclohexylcarbonates of 3-hydroxysteroids of the oyster row or 3,17-dicyclohexylcarbonates of 3,17-dihydroxysteroids of the oyster row.
ES271517A ES271517A1 (en) 1960-10-27 1961-10-26 A procedure for the preparation of new esteroid esters (Machine-translation by Google Translate, not legally binding)
BE609700A BE609700A (en) 1960-10-27 1961-10-27 Novel esters of steroid compounds and method of preparation
CH1244961A CH395978A (en) 1960-10-27 1961-10-27 Process for the preparation of new esters of steroid compounds

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR842375A FR1365267A (en) 1960-10-27 1960-10-27 Novel cyclohexylcarbonates of steroid compounds and method of preparation
FR850722A FR1172M (en) 1960-10-27 1961-01-25 New drug especially for the treatment of ovarian irregularities and insufficiencies.

Publications (1)

Publication Number Publication Date
FR1172M true FR1172M (en) 1962-03-12

Family

ID=8741608

Family Applications (3)

Application Number Title Priority Date Filing Date
FR842375A Expired FR1365267A (en) 1960-10-27 1960-10-27 Novel cyclohexylcarbonates of steroid compounds and method of preparation
FR848182A Active FR1203M (en) 1960-10-27 1960-12-28 New drug, in particular for the treatment of disorders due to hyperestrogenia or hypoandrogenism.
FR850722A Active FR1172M (en) 1960-10-27 1961-01-25 New drug especially for the treatment of ovarian irregularities and insufficiencies.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
FR842375A Expired FR1365267A (en) 1960-10-27 1960-10-27 Novel cyclohexylcarbonates of steroid compounds and method of preparation
FR848182A Active FR1203M (en) 1960-10-27 1960-12-28 New drug, in particular for the treatment of disorders due to hyperestrogenia or hypoandrogenism.

Country Status (1)

Country Link
FR (3) FR1365267A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531089A1 (en) * 1982-07-27 1984-02-03 Pharmascience Lab New oestrane derivatives intended for topical pharmacological application, and process for preparing them

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2531089A1 (en) * 1982-07-27 1984-02-03 Pharmascience Lab New oestrane derivatives intended for topical pharmacological application, and process for preparing them

Also Published As

Publication number Publication date
FR1203M (en) 1962-03-26
FR1365267A (en) 1964-07-03

Similar Documents

Publication Publication Date Title
FR1444M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
FR2609M (en) New drug for the treatment of staphylococcal and streptococcal infections.
FR362M (en) New drug for the treatment of staphylococcal infections and salmonellosis.
BE582173A (en) Advanced device for the treatment of threads.
FR2802M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
FR1172M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
FR126M (en) New drug, in particular for the treatment of postprandial or chronic hyperlipemia.
FR3187M (en) New drug in particular for the treatment of irregularities and ovarian insufficiencies.
FR365M (en) New drug for the treatment of staphylococcal and streptococcal infections.
FR1264810A (en) Products for hair treatment
FR363M (en) New drug for the treatment of trypanosomosis, salmonellosis and penicillofacial infections.
FR2743M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
FR385M (en) New drug for the treatment of staphylococcal infections and the like.
FR2413M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR2510M (en) New medicament usable for the treatment of staphylococcal infections and the like.
FR33F (en) New drug for the treatment of staphylococcal infections and the like.
BE598672A (en) Therapeutic composition for the treatment of hepatic disorders.
FR1729M (en) New drug, in particular for the treatment of inflammatory and painful manifestations.
BE630069A (en) Therapeutic composition for the treatment of parkinsonism.
FR2306M (en) New composition for the treatment of gastric and intestinal hyperacidities.
FR165M (en) New drug, especially for the treatment of muscle and bronchial spasms.
FR22M (en) New drug in particular for the treatment of acute or chronic articular rheumatism.
FR31M (en) New drug in particular for the treatment of arterial hypertension.
FR36M (en) New drug, in particular for the treatment of postprandial or acute hyperlipemia.